Abstract
Objective: To compare main lacrimal gland values through shear-wave elastography (SWE) in patients with low Schirmer value and unspecified Sjögren's syndrome (SS) with healthy controls.
Materials and Methods: Admitted to the ophthalmology department with Schirmer value <10 mm, randomly selected 46 eyes of 46 patients evaluated for Sjögren's syndrome (SS) in the rheumatology department between December 2022 and April 2023 were classified as low Schirmer group (LSG). Randomly selected 48 eyes of 48 patients at a similar age with Schirmer value >10 mm were included as controls. Main lacrimal gland SWE measurements in LSG and control groups were recorded and compared as meter/second (m/sec).
Results: Mean SWE values of the main lacrimal gland were measured as 2.78 ± 0.66 m/sec and 2.26 ± 0.29 m/sec in LSG and controls. SWE measurements were significantly higher in LSG patients than in controls (p<0.001). No significant correlation was found in the analysis between the Schirmer and the main lacrimal gland SWE values in LSG patients (p=0.702, r=0.058). No significant correlation was also detected between the Schirmer and main lacrimal gland SWE values in controls (p=0.097, r=0.242). No significant relationship was also found between age, gender, body mass index (BMI), and SWE values (p=0.351, p=0.493, p=0.328, respectively).
Conclusion: Mean SWE value of the main lacrimal gland was determined as significantly higher in patients with aqueous lacrimal insufficiency without SS than in controls. We consider that SWE measurements may be an imaging method to support the diagnosis of aqueous lacrimal insufficiency and used in follow-ups of those with dry eye syndrome (DES) in the future.
[http://dx.doi.org/10.1016/j.exer.2022.109101]
[http://dx.doi.org/10.1136/bjophthalmol-2018-312333]
[http://dx.doi.org/10.1001/archopht.1983.01040020385009]
[http://dx.doi.org/10.1053/j.sult.2006.09.002]
[http://dx.doi.org/10.7863/jum.2000.19.8.505]
[http://dx.doi.org/10.11152/mu-3217]
[http://dx.doi.org/10.11152/mu.2013.2066.173.iub]
[http://dx.doi.org/10.1016/j.jfo.2018.05.006]
[http://dx.doi.org/10.20452/pamw.16397]
[http://dx.doi.org/10.1016/j.medcli.2020.04.021]
[http://dx.doi.org/10.1046/j.1442-9071.2003.00634.x]
[http://dx.doi.org/10.1016/S0002-9394(03)00218-6]
[http://dx.doi.org/10.3238/arztebl.2015.0071]
[http://dx.doi.org/10.1097/ICO.0b013e318225415a]
[http://dx.doi.org/10.1016/S1542-0124(12)70081-2]
[http://dx.doi.org/10.1167/iovs.09-4445]
[http://dx.doi.org/10.1007/s00393-009-0517-4]
[http://dx.doi.org/10.1080/08820538.2022.2075706]
[http://dx.doi.org/10.1136/bjophthalmol-2020-316929]
[http://dx.doi.org/10.11152/mu-2164]
[http://dx.doi.org/10.5114/reum.2019.91273]
[http://dx.doi.org/10.55563/clinexprheumatol/20028h]
[http://dx.doi.org/10.3109/08830185.2012.748052]
[http://dx.doi.org/10.1001/archophthalmol.2011.364]
[http://dx.doi.org/10.1001/archophthalmol.2010.124]
[http://dx.doi.org/10.1111/1756-185X.13292]